Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,772 public trials 697 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Recruiting

Liquid Biopsy in Mature B-cell Tumors

NCT03280394

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations: Institute of Oncology Research Bellinzona, Canton Ticino, Switzerland

View Trial Details

Recruiting

A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies

NCT07220616

Conditions: B-Cell Non-Hodgkin Lymphoma, Hematologic Diseases, Hematologic Neoplasms, +12 more
Locations: Research Site New York, United States

Research Site Lille, France

Research Site Pierre-Bénite, France

Research Site Nagoya, Japan

View Trial Details

Recruiting

Epcoritamab and Lenalidomide in Treating Patients With Refractory or Relapsed Immunodeficiency-Related Large B-Cell Lymphoma

NCT06723457

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Northwestern University Chicago, Illinois, United States

View Trial Details

Recruiting

Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy

NCT06854159

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations: University of California Davis Comprehensive Cancer Center Sacramento, California, United States

View Trial Details

Recruiting

Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment

NCT07422610

Conditions: Advanced Malignancies and Hepatic Impairment, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Novartis Investigative Site Bordeaux, France

Novartis Investigative Site Saint-Herblain, France

Novartis Investigative Site Candiolo, TO, Italy

Novartis Investigative Site Pozuelo de Alarcón, Madrid, Spain

View Trial Details

Recruiting

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

NCT03810196

Conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +30 more
Locations: Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma

NCT06934382

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)

NCT05833724

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Chang Gung Memorial Hospital, Kaohsiung Kaohsiung City, Taiwan

Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan

Far eastern memorial hospital New Taipei City, Taiwan

Taichung Veterans General Hospital Taichung, Taiwan

View Trial Details

Recruiting

Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas

NCT06792734

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Levine Cancer Institute, Atrium Health Charlotte, North Carolina, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma

NCT06249191

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma, +10 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions